id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-6189-7939,FDA,FDA-2017-N-6189,Ref. 85_Donny_2015_Randomized trial of reduced-nicotine standard for cigarettes,Supporting & Related Material,Background Material,2018-08-21T04:00:00Z,2018,8,,,2018-08-21T18:52:20Z,,0,0,0900006483640913
FDA-2017-N-6189-0650,FDA,FDA-2017-N-6189,"Tobacco Product Standard for Nicotine Level of Combusted Cigarettes;
Extension of Comment Period",Proposed Rule,Extension of Comment Period,2018-06-08T04:00:00Z,2018,6,2018-06-08T04:00:00Z,,2018-07-16T08:46:05Z,2018-12368,0,0,09000064833985aa
FDA-2017-N-6189-0534,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from U.S. Tobacco Cooperative Inc.,Other,Request for Extension,2018-05-24T04:00:00Z,2018,5,2018-05-24T04:00:00Z,,2018-05-24T13:25:40Z,,0,0,09000064832c481d
FDA-2017-N-6189-0531,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from The Heritage Foundation,Other,Request for Extension,2018-05-23T04:00:00Z,2018,5,2018-05-23T04:00:00Z,,2018-05-23T14:11:04Z,,0,0,09000064832c0e59
FDA-2017-N-6189-0527,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from The Heartland Institute,Other,Electronic Regulation from Form,2018-05-22T04:00:00Z,2018,5,2018-05-22T04:00:00Z,,2018-05-22T20:00:15Z,,0,0,09000064832b2752
FDA-2017-N-6189-0484,FDA,FDA-2017-N-6189,Request for Extension of Comment Period form Kentucky Farm Bureau Federation,Other,Request for Extension,2018-05-18T04:00:00Z,2018,5,2018-05-18T04:00:00Z,,2018-05-18T11:47:45Z,,0,0,0900006483279624
FDA-2017-N-6189-0470,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from Commonwealth of Virginia Department of Agriculture and Consumer Services,Other,Request for Extension,2018-05-15T04:00:00Z,2018,5,2018-05-15T04:00:00Z,,2018-05-15T12:10:46Z,,0,0,090000648325d390
FDA-2017-N-6189-0459,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from ITG Brands,Other,Request for Extension,2018-05-11T04:00:00Z,2018,5,2018-05-11T04:00:00Z,,2018-05-11T17:37:30Z,,0,0,090000648325ad95
FDA-2017-N-6189-0458,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from North Carolina Department of Agriculture and Consumer Services  Agricultural Services,Other,Request for Extension,2018-05-11T04:00:00Z,2018,5,2018-05-11T04:00:00Z,,2018-05-11T17:37:57Z,,0,0,09000064832591e3
FDA-2017-N-6189-0455,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from R Street Institute,Other,Request for Extension,2018-05-11T04:00:00Z,2018,5,2018-05-11T04:00:00Z,,2018-05-11T17:18:47Z,,0,0,090000648325586e
FDA-2017-N-6189-0430,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from Universal Corporation,Other,Electronic Regulation from Form,2018-05-08T04:00:00Z,2018,5,2018-05-08T04:00:00Z,,2018-05-08T12:16:33Z,,0,0,09000064832234ff
FDA-2017-N-6189-0429,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from Altria Client Services LLC,Other,Electronic Regulation from Form,2018-05-08T04:00:00Z,2018,5,2018-05-08T04:00:00Z,,2018-05-08T12:16:26Z,,0,0,09000064832236b9
FDA-2017-N-6189-0433,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from Virginia Farm Bureau Federation,Other,Electronic Regulation from Form,2018-05-08T04:00:00Z,2018,5,2018-05-08T04:00:00Z,,2018-05-08T12:17:06Z,,0,0,09000064832282bb
FDA-2017-N-6189-0403,FDA,FDA-2017-N-6189,Nicotine Level ANPRM as Submitted to OMB Tab A of Direction to add documents to the docket in accordance with EO 12866,Other,Draft,2018-04-27T04:00:00Z,2018,4,2018-04-27T04:00:00Z,,2018-04-27T12:01:25Z,,0,0,09000064831e9654
FDA-2017-N-6189-0405,FDA,FDA-2017-N-6189,Nicotine Level ANPRM as Cleared by OMB Tab C of Direction to add documents to the docket in accordance with EO 12866,Other,Draft,2018-04-27T04:00:00Z,2018,4,2018-04-27T04:00:00Z,,2018-04-27T12:01:41Z,,0,0,09000064831e9656
FDA-2017-N-6189-0404,FDA,FDA-2017-N-6189,Nicotine Level ANPRM Track Changes Tab B of Direction to add documents to the docket in accordance with EO 12866,Other,Draft,2018-04-27T04:00:00Z,2018,4,2018-04-27T04:00:00Z,,2018-04-27T12:01:32Z,,0,0,09000064831e9655
FDA-2017-N-6189-0402,FDA,FDA-2017-N-6189,Memorandum to FDA DMS on Nicotine Level ANPRM,Other,Action Memo or Letter,2018-04-27T04:00:00Z,2018,4,2018-04-27T04:00:00Z,,2018-04-27T12:01:20Z,,0,0,09000064831e9653
FDA-2017-N-6189-0407,FDA,FDA-2017-N-6189,"Extension of Comment Period from North Carolina Farm Bureau Federation, Inc.",Other,Electronic Regulation from Form,2018-04-27T04:00:00Z,2018,4,2018-04-27T04:00:00Z,,2018-04-27T15:41:36Z,,0,0,09000064831ecc6f
FDA-2017-N-6189-0389,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from The Council for Burley Tobacco,Other,Request for Extension,2018-04-26T04:00:00Z,2018,4,2018-04-26T04:00:00Z,,2018-04-26T14:28:46Z,,0,0,09000064831c5edb
FDA-2017-N-6189-0208,FDA,FDA-2017-N-6189,"Request for Extension of Comment Period from National Association of Tobacco Outlets, Inc.",Other,Request for Extension,2018-04-18T04:00:00Z,2018,4,2018-04-18T04:00:00Z,,2018-04-19T02:01:31Z,,0,0,0900006483145105
FDA-2017-N-6189-0210,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from Convenience Distribution Association,Other,Request for Extension,2018-04-18T04:00:00Z,2018,4,2018-04-18T04:00:00Z,,2018-04-19T02:27:16Z,,0,0,0900006483173fda
FDA-2017-N-6189-0205,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from,Other,Electronic Regulation from Form,2018-04-18T04:00:00Z,2018,4,2018-04-18T04:00:00Z,,2018-04-19T00:56:59Z,,0,0,090000648305ba71
FDA-2017-N-6189-0204,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from Altria Client Services,Other,Request for Extension,2018-04-18T04:00:00Z,2018,4,2018-04-18T04:00:00Z,,2018-04-18T23:28:32Z,,0,0,090000648303edba
FDA-2017-N-6189-0209,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from The Heartland Institute,Other,Request for Extension,2018-04-18T04:00:00Z,2018,4,2018-04-18T04:00:00Z,,2018-04-19T02:20:12Z,,0,0,090000648314fa61
FDA-2017-N-6189-0207,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from RAI Services Company,Other,Request for Extension,2018-04-18T04:00:00Z,2018,4,2018-04-18T04:00:00Z,,2018-04-19T01:56:22Z,,0,0,090000648304ef16
FDA-2017-N-6189-0206,FDA,FDA-2017-N-6189,Request for Extension of Comment Period from Altria Client Services,Other,Request for Extension,2018-04-18T04:00:00Z,2018,4,2018-04-18T04:00:00Z,,2018-04-19T01:26:04Z,,0,0,09000064830854b5
FDA-2017-N-6189-0079,FDA,FDA-2017-N-6189,Reference 111_Lindson_2010_Reduction Versus Abrupt Cessation in Smokers Who Want to Quit,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:21Z,,0,0,0900006483017c78
FDA-2017-N-6189-0164,FDA,FDA-2017-N-6189,Reference 116_CRM_2005_Determination of Nicotine in Tobacco and Tobacco Products by Gas Chromatographic Analysis,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:55:08Z,,0,0,0900006483017c7d
FDA-2017-N-6189-0102,FDA,FDA-2017-N-6189,Reference 123_NRP_1989_Nicotine Reduction Program,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:36Z,,0,0,0900006483017c8a
FDA-2017-N-6189-0100,FDA,FDA-2017-N-6189,Reference 125_Ding_2017_Chemical Characterization of Mainstream Smoke from Spectrum Variable Nicotine Research Cigarettes,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:35Z,,0,0,0900006483017c8c
FDA-2017-N-6189-0096,FDA,FDA-2017-N-6189,Reference 129_Har_Monthly Project Development Report,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:32Z,,0,0,0900006483017c97
FDA-2017-N-6189-0111,FDA,FDA-2017-N-6189,Reference 151_Boswall_1971_Project T-6534  Tobacco for Reconstitution,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:44Z,,0,0,0900006483017cc0
FDA-2017-N-6189-0172,FDA,FDA-2017-N-6189,Reference 80_Counts l_2005_Smoke composition and predicting realtionships for international commercial cigarettes,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:56:35Z,,0,0,0900006483017dc0
FDA-2017-N-6189-0083,FDA,FDA-2017-N-6189,Reference 107_Rose 06_Precessation Treatment with Nicotine Skin Patch Facilitates Smoking Cessation,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:24Z,,0,0,0900006483017e38
FDA-2017-N-6189-0138,FDA,FDA-2017-N-6189,Reference 161_Hash_2014_Reducing Levels of Nicotinice Alkaloids in Plants,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:53:03Z,,0,0,0900006483017eb2
FDA-2017-N-6189-0134,FDA,FDA-2017-N-6189,Reference 165_Ridomil_800000 D.R.S. Ridomil Experiment,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:53:01Z,,0,0,0900006483017eca
FDA-2017-N-6189-0016,FDA,FDA-2017-N-6189,Reference 5_Ben 07_Nicotine and Carcinogen Exposure With Smoking of Progressively Reduced Nicotine Content Cigarettes,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:27Z,,0,0,0900006483017bc9
FDA-2017-N-6189-0003,FDA,FDA-2017-N-6189,Reference 18_Lenk_2014_Do Sources of Cigarettes Among Adolescents Vary by Age Over Time,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:19Z,,0,0,0900006483017bfc
FDA-2017-N-6189-0031,FDA,FDA-2017-N-6189,Reference 29_Fong_2004_The Near-Universal Experience of Regret Among Smokers in Four Countries Findings From the International Tobacco Control Policy,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:36Z,,0,0,0900006483017c23
FDA-2017-N-6189-0028,FDA,FDA-2017-N-6189,"Reference 32_Christensen_2018_StudyAssociation of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population",Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:35Z,,0,0,0900006483017c2c
FDA-2017-N-6189-0024,FDA,FDA-2017-N-6189,Reference 36_94 SG_Youth & Tobacco Preventing Tobacco Use Among Young People,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:32Z,,0,0,0900006483017c33
FDA-2017-N-6189-0165,FDA,FDA-2017-N-6189,Reference 79_ART_Alkaloid Reduced Tobacco,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:55:09Z,,0,0,0900006483017dbf
FDA-2017-N-6189-0082,FDA,FDA-2017-N-6189,"Reference 108_Walker 12_The Combined Effect of Very Low Nicotine Content Cigarettes, Used as an Adjunct to Usual Quitline Care",Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:23Z,,0,0,0900006483017e39
FDA-2017-N-6189-0097,FDA,FDA-2017-N-6189,Reference 128_Wayne_2012_Tobacco Industry Research on Modification of Nicotine Content in Tobacco,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:33Z,,0,0,0900006483017c8f
FDA-2017-N-6189-0123,FDA,FDA-2017-N-6189,Reference 139_Crouse_1987_Communication with Michael Ogden RJR Bowman Gray Development Center,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:54Z,,0,0,0900006483017ca9
FDA-2017-N-6189-0115,FDA,FDA-2017-N-6189,Reference 147_Hempfling_1987_Philip Morris and the New Biotechnology,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:48Z,,0,0,0900006483017cbc
FDA-2017-N-6189-0051,FDA,FDA-2017-N-6189,Reference 47_CDC 5708_2008_Surveillance for cancers associated with tobacco use-United States_1999-2004,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:50Z,,0,0,0900006483017d4e
FDA-2017-N-6189-0044,FDA,FDA-2017-N-6189,Reference 54_Henn 98_Reducing the Addictiveness of Cigarettes,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:45Z,,0,0,0900006483017d7a
FDA-2017-N-6189-0166,FDA,FDA-2017-N-6189,Reference 78_NIH_Notice of Availability of Nicotine Research Cigarettes Through NIDA’s Drug Supply Program,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:55:10Z,,0,0,0900006483017dbe
FDA-2017-N-6189-0008,FDA,FDA-2017-N-6189,Reference 13_IOM 07_2007_Ending the Tobacco Problem  A Blueprint for the Nation,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:23Z,,0,0,09000064830178c1
FDA-2017-N-6189-0130,FDA,FDA-2017-N-6189,Reference 169_Geiss 75_Bw Process VI  Metabolism of Nicotine and Other Biochemistry of the Bw Process,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:59Z,,0,0,0900006483017ece
FDA-2017-N-6189-0015,FDA,FDA-2017-N-6189,Reference 6_NEJM_2015_Smoking and Mortality Beyond Established Causes,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:26Z,,0,0,0900006483017bca
FDA-2017-N-6189-0022,FDA,FDA-2017-N-6189,Reference 38_Choi_1997_Which Adolescent Experimenters Progress to Established Smoking in the United States,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:31Z,,0,0,0900006483017c35
FDA-2017-N-6189-0109,FDA,FDA-2017-N-6189,Reference 152_Evans_1971_Low Nicotine Tobacco,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:42Z,,0,0,0900006483017cc1
FDA-2017-N-6189-0084,FDA,FDA-2017-N-6189,Reference 106_Hats Kot 10_Reduced Nicotine Content Cigarettes Effects on Toxicant Exposure Dependence and Cessation,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:25Z,,0,0,0900006483017e37
FDA-2017-N-6189-0076,FDA,FDA-2017-N-6189,Reference 114_TobLab_2014_Standard operating procedure for determination of nicotine in cigarette tobacco filler,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:20Z,,0,0,0900006483017c7b
FDA-2017-N-6189-0161,FDA,FDA-2017-N-6189,Reference 133_Dunsby_2004_A nicotine delivery device without the nicotine Tobacco industry development of low nicotine cigarettes,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:55:06Z,,0,0,0900006483017c9c
FDA-2017-N-6189-0160,FDA,FDA-2017-N-6189,Reference 134_Tso 1972_The Potential for Producing Safer Cigarette Tobacco,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:55:06Z,,0,0,0900006483017c9d
FDA-2017-N-6189-0087,FDA,FDA-2017-N-6189,Reference 103_Benowitz 2006_Nicotine Intake and Dose Response When Smoking Reduced-Nicotine Content Cigarettes,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:26Z,,0,0,0900006483017e34
FDA-2017-N-6189-0019,FDA,FDA-2017-N-6189,Reference 2_Ben 13_Reducing the nicotine content to make cigarettes less addictive,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:29Z,,0,0,0900006483017bc6
FDA-2017-N-6189-0004,FDA,FDA-2017-N-6189,Reference 17_10 SG_How Tobacco Smoke Causes Disease The Biology and Behavioral Basis for Smoking-Attributable Disease,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:20Z,,0,0,0900006483017bfa
FDA-2017-N-6189-0027,FDA,FDA-2017-N-6189,"Reference 33_Rodriguez_2010_The Association of Pipe and Cigar Use With Cotinine Levels, Lung Function, and Airflow Obstruction",Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:34Z,,0,0,0900006483017c2f
FDA-2017-N-6189-0070,FDA,FDA-2017-N-6189,Reference 63_Fiore 15_Reduced-nicotine cigarettes_A promising regulatory pathway,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:02Z,,0,0,0900006483017c56
FDA-2017-N-6189-0062,FDA,FDA-2017-N-6189,Reference 71_Jacob_1999_Minor tobacco alkaloids as biomarkers for tobacco use,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:57Z,,0,0,0900006483017c5e
FDA-2017-N-6189-0074,FDA,FDA-2017-N-6189,Reference 59_06 SG_The health consequences of involuntary exposure to tobacco smoke,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:04Z,,0,0,0900006483017d7f
FDA-2017-N-6189-0145,FDA,FDA-2017-N-6189,Reference 154_BAT_1973_Research and Development Department  Progress in 1972 – Plans for 1973,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:53:06Z,,0,0,0900006483017eaa
FDA-2017-N-6189-0017,FDA,FDA-2017-N-6189,"Reference 4_Hats 10_Reduced Nicotine Content Cigarettes Effects on Toxic Exposure, Dependence, and Cessation",Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:28Z,,0,0,0900006483017bc8
FDA-2017-N-6189-0039,FDA,FDA-2017-N-6189,Reference 21_CDC 6044_2011_Quitting Smoking Among Adults United States 2001- 2010,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:41Z,,0,0,0900006483017bff
FDA-2017-N-6189-0025,FDA,FDA-2017-N-6189,Reference 35_Weglicki_2008_Tobacco Use Assessment What Exactly Is Your Patient Using and Why Is It Important to Know,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:33Z,,0,0,0900006483017c31
FDA-2017-N-6189-0068,FDA,FDA-2017-N-6189,Reference 65_Scherer_1999_Smoking behaviour and compensation-a review of the literature,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:01Z,,0,0,0900006483017c58
FDA-2017-N-6189-0067,FDA,FDA-2017-N-6189,Reference 66_Grubbs_1991_Process for removal of basic materials,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:00Z,,0,0,0900006483017c59
FDA-2017-N-6189-0148,FDA,FDA-2017-N-6189,Reference 173_90 SG_1990_The Health Benefits of Smoking Cessation,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:53:13Z,,0,0,0900006483017cdf
FDA-2017-N-6189-0153,FDA,FDA-2017-N-6189,Reference 178_Taylor_2002_Benefits of Smoking Cessation for Longevity_AJPH,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:53:16Z,,0,0,0900006483017ce5
FDA-2017-N-6189-0060,FDA,FDA-2017-N-6189,"Reference 73_Djordjevic_1990_CORESTA Symposium, Kallithea Greece",Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:56Z,,0,0,0900006483017db8
FDA-2017-N-6189-0171,FDA,FDA-2017-N-6189,Reference 77_Patent_Reducing Levels of Nicotinic Alkaloids in Plants,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:56:27Z,,0,0,0900006483017dbd
FDA-2017-N-6189-0129,FDA,FDA-2017-N-6189,Reference 170_Gravely_1973_Bw Process  IV Evaluation of Low Nicotine Cigarettes Use for Consumer Product Testing,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:58Z,,0,0,0900006483017ecf
FDA-2017-N-6189-0158,FDA,FDA-2017-N-6189,Reference 93_Perkins_2008_Mood Influences on Acute Smoking Responses Are Independent of Nicotine Intake and Dose Expectancy,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:55:03Z,,0,0,0900006483017c68
FDA-2017-N-6189-0184,FDA,FDA-2017-N-6189,Reference 94_Gross_1997_Nicotine Containing Versus De Nicotinized Cigarettes Effects on Craving and Withdrawal,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T16:03:58Z,,0,0,0900006483017c69
FDA-2017-N-6189-0091,FDA,FDA-2017-N-6189,Reference 99_Wu_2002_Determination of Nicotine and Other Minor Alkaloids in International Cigarettes by Solid Phase Microextraction and Gas Chromatography Mass,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:29Z,,0,0,0900006483017c6f
FDA-2017-N-6189-0108,FDA,FDA-2017-N-6189,Reference 117_Wu 98_Analytical Determination of Nicotine in Tobacco by Supercritical Fluid Chromatography−Ion Mobility Detection,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:41Z,,0,0,0900006483017c7e
FDA-2017-N-6189-0099,FDA,FDA-2017-N-6189,"Reference 126_Mon.7_The FTC Cigarette Test Method for Determining Tar, Nicotine, and Carbon Monoxide Yields of U.S. Cigarettes",Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:34Z,,0,0,0900006483017c8d
FDA-2017-N-6189-0095,FDA,FDA-2017-N-6189,Reference 130_unnamed_2016_Unnamed Report,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:31Z,,0,0,0900006483017c98
FDA-2017-N-6189-0126,FDA,FDA-2017-N-6189,Reference 136_Borriston_1984_.  Final Report 14-Day Single Dose Subacute Toxicity Study in the Rat With A-7 Borriston Project,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:57Z,,0,0,0900006483017c9f
FDA-2017-N-6189-0120,FDA,FDA-2017-N-6189,Reference 142_Roselius_1879_Process for the Extraction of Nicotine From Tobacco,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:52Z,,0,0,0900006483017caf
FDA-2017-N-6189-0113,FDA,FDA-2017-N-6189,Reference 149_Sensa_1992_Sensa Business Plan Executive Summary,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:46Z,,0,0,0900006483017cbe
FDA-2017-N-6189-0047,FDA,FDA-2017-N-6189,Reference 51_Kenford_1994_Predicting Smoking Cessation Who Will Quit With and Without the Nicotine Patch,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:47Z,,0,0,0900006483017d52
FDA-2017-N-6189-0176,FDA,FDA-2017-N-6189,Reference 84_Sof rev_2012_The reinforcement threshold for nicotine as a target for tobacco control,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:58:32Z,,0,0,0900006483017df4
FDA-2017-N-6189-0182,FDA,FDA-2017-N-6189,Reference 90_Eid_2005_Placebo cigarettes in a spaced smoking paradigm,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T16:02:48Z,,0,0,0900006483017dfa
FDA-2017-N-6189-0131,FDA,FDA-2017-N-6189,Reference 168_Geiss_1972_Bw Process I  Reductions of Tobacco Nicotine Using Selected Bacteria,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:59Z,,0,0,0900006483017ecd
FDA-2017-N-6189-0009,FDA,FDA-2017-N-6189,Reference 12_Johnston 2005_Monitoring the Future national survey results on drug use 1975-2004,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:23Z,,0,0,09000064830178c0
FDA-2017-N-6189-0021,FDA,FDA-2017-N-6189,Reference List_Tobacco Product Standard for Nicotine Level of Combusted Cigarettes,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:30Z,,0,0,0900006483017bc4
FDA-2017-N-6189-0018,FDA,FDA-2017-N-6189,Reference 3_Hats Heis 13_Dose Response Effects of Spectrum Research Cigarettes,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:28Z,,0,0,0900006483017bc7
FDA-2017-N-6189-0040,FDA,FDA-2017-N-6189,Reference 20_Grucza_2013_Long-Term Effects of Laws Governing Youth Access to Tobacco,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:42Z,,0,0,0900006483017bfe
FDA-2017-N-6189-0173,FDA,FDA-2017-N-6189,Reference 81_B&H 94_Establishing a nicotine threshold for addiction - the implications for tobacco regulation,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:56:40Z,,0,0,0900006483017df1
FDA-2017-N-6189-0139,FDA,FDA-2017-N-6189,"Ref. 160_Cohen_1971_Minutes of Meeting on May 6, 1971",Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:53:03Z,,0,0,0900006483017eb0
FDA-2017-N-6189-0098,FDA,FDA-2017-N-6189,"Reference 127_Farone_U.S. District Court for the District of Columbia United States of America, Plaintiff, versus Philip Morris, USA, et al., defendants",Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:34Z,,0,0,0900006483017c8e
FDA-2017-N-6189-0124,FDA,FDA-2017-N-6189,Reference 138_PM_Untitled Chart,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:55Z,,0,0,0900006483017ca8
FDA-2017-N-6189-0122,FDA,FDA-2017-N-6189,Reference 140_Ruiz_2008_Supercritical Fluid Extraction of Tobacco Leaves A Preliminary Study on the Extraction of Solanesol,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:53Z,,0,0,0900006483017caa
FDA-2017-N-6189-0118,FDA,FDA-2017-N-6189,Reference 144_Crouse 76_Nicotine Extraction Preliminary Study of Methods for High Nicotine Leaf Extraction June 20 1976,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:52:51Z,,0,0,0900006483017cb1
FDA-2017-N-6189-0053,FDA,FDA-2017-N-6189,Reference 45_Chaiton_2016_Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers,Supporting & Related Material,Background Material,2018-03-16T04:00:00Z,2018,3,,,2018-03-16T15:51:51Z,,0,0,0900006483017d4c